AmirAli Talasaz, the Co-Chief Executive Officer of $GH, sold 50,000 shares of the company on 05-12-2026 for an estimated $5,016,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.3% of their shares of this class of stock. Following this trade, they now own 2,096,504 shares of this class of $GH stock.
$GH Insider Trading Activity
$GH insiders have traded $GH stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.
Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:
- AMIRALI TALASAZ (Co-Chief Executive Officer) has made 0 purchases and 7 sales selling 150,000 shares for an estimated $15,521,473.
- HELMY ELTOUKHY (Co-Chief Executive Officer) has made 0 purchases and 2 sales selling 90,565 shares for an estimated $9,402,220.
- MICHAEL BRIAN BELL (Chief Financial Officer) has made 0 purchases and 13 sales selling 83,362 shares for an estimated $8,549,852.
- TERILYN J. MONROE (Chief People Officer) has made 0 purchases and 14 sales selling 77,601 shares for an estimated $8,303,494.
- KUMUD KALIA (Chief Information Officer) has made 0 purchases and 3 sales selling 42,000 shares for an estimated $4,021,864.
- CHRIS FREEMAN (Chief Commercial Officer) has made 0 purchases and 11 sales selling 31,452 shares for an estimated $3,241,621.
- IAN T CLARK has made 0 purchases and 3 sales selling 28,611 shares for an estimated $3,066,817.
- DARYA CHUDOVA (Chief Technology Officer) has made 0 purchases and 3 sales selling 28,386 shares for an estimated $2,985,111.
- MEDINA MANUEL HIDALGO has made 0 purchases and 4 sales selling 2,550 shares for an estimated $250,246.
- MUSA TARIQ has made 0 purchases and 4 sales selling 696 shares for an estimated $63,429.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$GH Hedge Fund Activity
We have seen 279 institutional investors add shares of $GH stock to their portfolio, and 204 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 2,842,566 shares (-87.5%) from their portfolio in Q4 2025, for an estimated $290,339,691
- ALLIANCEBERNSTEIN L.P. added 1,761,785 shares (+1262.7%) to their portfolio in Q4 2025, for an estimated $179,948,719
- FMR LLC added 1,572,168 shares (+190.7%) to their portfolio in Q4 2025, for an estimated $160,581,239
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,414,441 shares (+33.5%) to their portfolio in Q4 2025, for an estimated $144,471,003
- POINT72 ASSET MANAGEMENT, L.P. added 1,396,754 shares (+1363.8%) to their portfolio in Q4 2025, for an estimated $142,664,453
- DEEP TRACK CAPITAL, LP removed 1,354,086 shares (-32.6%) from their portfolio in Q4 2025, for an estimated $138,306,344
- CADIAN CAPITAL MANAGEMENT, LP removed 1,218,563 shares (-56.9%) from their portfolio in Q4 2025, for an estimated $124,464,024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$GH Revenue
$GH had revenues of $301.7M in Q1 2026.
You can track GH financials on Quiver Quantitative's GH stock page.
You can access data on GH stock through the Quiver Quantitative API.
$GH Congressional Stock Trading
Members of Congress have traded $GH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GH stock by members of Congress over the last 6 months:
- SENATOR SHELDON WHITEHOUSE purchased up to $15,000 on 11/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$GH Analyst Ratings
Wall Street analysts have issued reports on $GH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/20/2026
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
- Mizuho issued a "Outperform" rating on 12/17/2025
To track analyst ratings and price targets for $GH, check out Quiver Quantitative's $GH forecast page.
$GH Price Targets
Multiple analysts have issued price targets for $GH recently. We have seen 15 analysts offer price targets for $GH in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Daniel Markowitz from Evercore ISI Group set a target price of $95.0 on 05/08/2026
- Casey Woodring from JP Morgan set a target price of $135.0 on 05/08/2026
- Luke Sergott from Barclays set a target price of $120.0 on 05/08/2026
- David Westenberg from Piper Sandler set a target price of $130.0 on 02/24/2026
- Patrick Donnelly from Citigroup set a target price of $150.0 on 02/20/2026
- Puneet Souda from Leerink Partners set a target price of $180.0 on 02/20/2026
- Dan Brennan from TD Cowen set a target price of $135.0 on 02/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
